Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Publications
  • In the News

Navidea Biopharmaceuticals Announces Extension of NYSE American Listing

Feb 1, 2019

Navidea Biopharmaceuticals Announces Decision by Ohio Supreme Court

Jan 24, 2019

Navidea Biopharmaceuticals Announces Patent Extension for Lymphoseek®

Dec 7, 2018

Navidea Biopharmaceuticals Appoints Adam Cutler to Board of Directors

Nov 29, 2018

Navidea Biopharmaceuticals Appoints Dr. Michael Rosol as Chief Medical Officer

Nov 29, 2018

Navidea Biopharmaceuticals to Present at the 11th Annual LD Micro Event 2018

Nov 28, 2018

Navidea Biopharmaceuticals Announces Presentation at the Radiological Society of North America (RSNA) 104th Scientific Assembly and Annual Meeting 2018

Nov 27, 2018

Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of Directors

Nov 26, 2018

Navidea Biopharmaceuticals Reports Third Quarter 2018 Financial Results

Nov 7, 2018

Navidea Biopharmaceuticals Schedules Third Quarter 2018 Earnings Conference Call and Business Update

Nov 1, 2018
    • 1...
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • ...43
    © 2023 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap